ViaDerma Inc (VDRM)

[Braden32601]

PR from 4/5/17 means MID MAY for Approval...Viaderma Inc (OTCMKTS:VDRM) is a specialty pharmaceutical company devoted to bringing new products to market, recently announced that the Company has filed with the (FDA) Food and Drug Administration for a new over the counter or OTC version of its “Premature Ejaculation Drug”. The new “OTC Drug” should have FDA registration approval in approximately 8 weeks and the Company’s name of the new drug will portray prolonged endurance.